Oral MYC condensate modulator drives tumor regression and stasis in preclinical modelsDisruption of MYC condensates enables targeted inhibition ...

The Arkansas Integrative Metabolic Research Center (AIMRC) will host Dr. Kevin Murach, an associate professor of exercise, at 12:55 p.m. on Wednesday, April 29, in CHEM 0144.

Efforts to develop effective therapies for MYC-amplified Group 3 medulloblastoma (G3-MB) are hindered by an incomplete ...

The MYC oncogene family plays an important role in neoplastic disease, and has been extensively studied over decades. Evidence showing the N-terminal and C-terminal regions of MYC can function as a ...

Mice with one rather than the normal two copies of the gene Myc (also found in humans) lived 15 percent longer and had considerably healthier lives than normal mice, according to a new Brown ...

Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. The poor prognosis is due in part both to late detection and the cancer’s capacity to adapt and ...

Myc is one of the most frequently mutated, widely studied, and overexpressed genes implicated in cancer. Most mutations in the myc gene lead to its constitutive expression. The myc gene codes for the ...

Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with ...

A tumor-specific enhancer on extrachromosomal DNA drives MYC expression, revealing a new therapeutic target in high-risk ...